Form 4 for SI SHOULDER INNOVATIONS, INC.
Accepted 2026-04-30 16:33:54 ET · period of report 2026-04-30 · accession 0002070664-26-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-04-30 16:33 | 2026-04-30 | SI | Ball Robert Joseph | CEO, Executive COB, Dir | M - OptEx | $2.48 | +10.0K | 300.0K | +3% | +$24.8K |
| D | 2026-04-30 16:33 | 2026-04-30 | SI | Ball Robert Joseph | CEO, Executive COB, Dir | M - OptEx | $0.00 | -10.0K | 309.8K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-30 | M | A | 10,000 | $2.48 | 300,018 | D | — | — | (F1) Includes the following shares received without consideration as in-kind distributions: (i) 4,400 shares from Cultivate MD Capital Fund I, LLC; and (ii) 6,752 shares from Genesis Investment Holdings. In prior reports, the reporting person reported beneficial ownership of 278,866 shares of Shoulder Innovations common stock held directly. |
| 2 | Derivative | Stock Option | 2026-04-30 | M | D | 10,000 | $0.00 | 309,756 | D | $2.48 · — to 2033-05-17 | 10,000 Common Stock | (F2) The stock option vested as to one-fourth of the underlying shares on May 17, 2024, and the remaining shares vest in 36 equal increments on the last day of each calendar month thereafter. |